Tumor cells cotransduced with B7.1 and γ-IFN induce effective rejection of established parental tumor
- 1 February 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (2) , 253-262
- https://doi.org/10.1038/sj.gt.3300820
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 24 references indexed in Scilit:
- Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.The Journal of Experimental Medicine, 1995
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.The Journal of Experimental Medicine, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.The Journal of Experimental Medicine, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- PRECURSOR FREQUENCY AND LYTIC SPECIFICITY OF INTERLEUKIN 2 AND INTERLEUKIN 4-RESPONSIVE MURINE LYMPHOCYTESTransplantation, 1990
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989